Caricamento...
At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies
The chimeric antigen receptor (CAR) represents the epitome of cellular engineering and is one of the best examples of rational biologic design of a synthetic molecule. The CAR is a single polypeptide with modular domains, consisting of an antibody‐derived targeting moiety, fused in line with T cell‐...
Salvato in:
| Pubblicato in: | J Leukoc Biol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608016/ https://ncbi.nlm.nih.gov/pubmed/27789538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5BT1215-556RR |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|